Atlas Trials

Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy

Clinical trial NCT06627257 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06627257
Sponsor
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Leprosy
Start date
2025-01-02
Primary completion
2026-03-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.